Lamotrigine, an anticonvulsant and mood stabilizer, is used off-label in Visual Snow Syndrome to modulate neuronal hyperexcitability and glutamate neurotransmission, potentially reducing cortical hyperactivity and abnormal visual processing. Its primary mechanism involves blocking voltage-dependent sodium channels and inhibiting glutamate release, which may help mitigate the persistent visual disturbances characteristic of the syndrome.